All In Biotech

Drug Trial Radar · NCT04044690

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra®) in Adults With Dermatomyositis (DM) - The RECLAIIM Study

Last checked: Nov 19, 2026Latest source record: Dec 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 134 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

134

Actual

Start

Oct 21, 2019

Primary completion

Dec 2, 2024

Study completion Dec 2, 2024

Sponsor

Lead sponsor
CSL BehringIndustry
Sponsor type
Industry
First posted
Aug 5, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 3, multicenter, randomized, placebo-controlled, double-blind study of IgPro20 (subcutaneous Ig) treatment in adult subjects with dermatomyositis (DM). The primary objective of this study is to assess the efficacy of IgPro20 subcutaneous (SC) doses in comparison to placebo in adult subjects with DM, as measured by responder status based on Total Improvement Score (TIS) assessments.

Conditions

  • Dermatomyositis

Interventions

  • human immunoglobulin GDrug

    human immunoglobulin G administered subcutaneously

  • PlaceboDrug

    contains 2% human albumin, similar excipients as IgPro20 (Hizentra), same volume, same duration, administered subcutaneously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Responder RateTime frame: At Week 25

Locations

76 sites in 14 countries. Site status is shown where the registry gives one.

  • 8401117 - Arizona Arthritis & Rheumatology Research

    Glendale, Arizona

  • 8401199 - Neuromuscular Research Center

    Phoenix, Arizona

  • 8401129 - UCLA - Rheumatology Los Angeles

    Los Angeles, California

  • 8401473 - RecioMed Clinical Research Network, Inc.

    Boynton Beach, Florida

  • 8401160 - Center For Rheumatology

    Fort Lauderdale, Florida

  • 8401132 - Omega Research Maitland

    Orlando, Florida

  • 8401107 - Morsani Center for Advanced Health Care (CAHC)

    Tampa, Florida

  • 8401152 - The University of Kansas Medical Center

    Fairway, Kansas

  • 8401476 - DS Research

    Louisville, Kentucky

  • 8401487 - Ohio State University

    Columbus, Ohio

  • 8401486 - Oregon Health and Science University

    Portland, Oregon

  • 8401210 - University of Pennsylvania

    Philadelphia, Pennsylvania

  • 8401151 - Biomedical Science Tower

    Pittsburgh, Pennsylvania

  • 8401474 - West Tennessee Research Institute, LLC

    Jackson, Tennessee

  • 8401115 - The University of Texas Medical School at Houston

    Houston, Texas

  • 0320084 - DIM Clinica Privada

    Buenos Aires, Argentina

  • 0320081 - Fundacion Respirar

    Buenos Aires, Argentina

  • 0320077 - Centro Medico Privado de Reumatolgia

    San Miguel de Tucumán, Argentina

  • 0320083 - Hospital Italiano de Buenos Aires

    Ciudad Autónoma Buenos Aires, Buenos Aires, Argentina

  • 0560050 - Ghent Universit Hospital (UZ Gent)

    Ghent, Belgium

  • 0560048 - Universitair Ziekenhuis (UZ) Leuven

    Leuven, Belgium

  • 0560056 - Universitair Ziekenhuis Leuven

    Leuven, Belgium

  • 0560049 - CHU de Liège - Sart Tilman

    Liège, Belgium

  • 2500146 - CHU De Dijon Hopital Du Bocage

    Dijon, France

  • 2500188 - Centre Hospitalier Regional Universitaire de Lille

    Lille, France

  • 2500133 - CHU - Hospital de la Timone

    Marseille, France

  • 2500135 - CHU Nice-Hopital Archet I

    Nice, France

  • 2500132 - Hopital Pitie-Salpetriere

    Paris, France

  • 2500144 - Hopitaux Universitaire de Strasbourg

    Strasbourg, France

  • 2760203 - Charité

    Berlin, Germany

  • 2760211 - Charité - Universitätsmedizin Berlin

    Berlin, Germany

  • 2760199 - University Hospital Köln

    Cologne, Germany

  • 2760271 - Universitatsklinikum Carl Gustav Carus TU Dresden

    Dresden, Germany

  • 2760273 - Hautklinik des Uni-Klinikums Erlangen

    Erlangen, Germany

  • 2760036 - University Medicine Göttingen

    Göttingen, Germany

  • 2760201 - Medizinische Hochschule Hannover (MHH)

    Hanover, Germany

  • 2760210 - University of Münster

    Münster, Germany

  • 2760212 - University Hospital Of Tuebingen

    Tübingen, Germany

  • 2760268 - University of Ulm

    Ulm, Germany

  • 3480048 - University of Debrecen

    Debrecen, Hungary

Showing 40 of 76 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.